博瑞医药：关于对外投资暨关联交易的公告

Core Viewpoint - The company, 博瑞医药, plans to increase its investment in 苏州极客基因科技有限公司 by 50 million yuan, raising its stake from 4.0816% to 12.8015% [2] Group 1: Investment Details - The company will subscribe to an additional registered capital of 437,100 yuan in 极客基因, with the remaining amount allocated to the company's capital reserve [2] - The investment has been approved by the company's board and will be submitted for shareholder approval [2] Group 2: Related Parties - The chairman of the company, 袁建栋, is a director at 极客基因 and is involved in the investment decision-making committees of related investment partnerships [2] - The transaction is classified as a related party transaction due to the involvement of 袁建栋 and associated entities [2]